--- title: Designing Studies With Recurrent Events - Model choices, pitfalls and group sequential design description: [Free Webinar] Join us as we cover the important design considerations for analysing recurring events and counts. Discover the different options for the analysis and what sample size calculations available. image: https://www.statsols.com/hubfs/Master-Images/Webinars/Designing-studies-with-recurring-events-and-counts/Designing-studies-with-recurrent-events-Webinar-on-demand.jpg --- [![nQuery Logo-White](https://www.statsols.com/hs-fs/hubfs/nQuery%20Logo-White.png?width=705&height=175&name=nQuery%20Logo-White.png "nQuery Logo-White")](https://www.statsols.com/) ** ** ![Sample size and power training for use in clinical trials](https://www.statsols.com/hs-fs/hubfs/Master_Images/___PageImages/Software_Training/Sample%20size%20and%20power%20training%20for%20use%20in%20clinical%20trials.jpeg?width=1000&name=Sample%20size%20and%20power%20training%20for%20use%20in%20clinical%20trials.jpeg "Sample size and power training for use in clinical trials") #### Webinar # Designing studies with recurrent events # Model choices, pitfalls and group sequential design ### This webinar is now over. You can watch on demand now ** #### About the webinar In this free webinar, we will examine the important design considerations for analyzing recurring events and counts. Recurring events are common in clinical trials (e.g. COPD exacerbations, MS relapses) but have often been analysed using survival models or other approximations. But these simple approaches fail to use every event. This has led to increasing interest in recurring event and count models and how these allow us to analyse all recurring events or counts and thus provide additional insight and power. > In this webinar, we will cover the different options for the analysis of recurring events and counts, the sample size calculations available for this area including adjustments for unequal follow-up and dropout, and extensions of the group sequential design framework to the recurring event endpoint. ** #### In this free webinar you will learn about:  - What are recurring events and how should we analyse them - The design issues, models and pitfalls in recurring events - Sample size determination for recurring events and counts - Group sequential design for recurring events ** #### Duration - 60 minutes **Speaker:** Ronan Fitzpatrick, Head of Statistics, Statsols ### Watch Now All info submitted is secure. View our [privacy policy](https://www.statsols.com/privacy-policy). ** About Our Host **Ronan Fitzpatrick ![Ronan Fitzpatrick - nQuery Head of Statistics - Circle Image](https://www.statsols.com/hs-fs/hubfs/Staff_Photos/Headshots/Ronan%20Fitzpatrick%20-%20nQuery%20Head%20of%20Statistics%20-%20Circle%20Image.png?width=150&name=Ronan%20Fitzpatrick%20-%20nQuery%20Head%20of%20Statistics%20-%20Circle%20Image.png) Ronan Fitzpatrick is Head of Statistics at Statsols and the Lead Researcher for nQuery Sample Size Software. He has been a guest lecturer for many institutions including the FDA. **Reducing the risk & cost of clinical trials, for innovative organizations such as:** ![Sanofi-updated-grey](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Sanofi-updated-grey.jpg?width=80&name=Sanofi-updated-grey.jpg "Sanofi-updated-grey") ![worldwide-clinical-trials](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/worldwide-clinical-trials.jpg?width=300&name=worldwide-clinical-trials.jpg "worldwide-clinical-trials") ![Covance-G_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Covance-G_Logo.jpg?width=354&name=Covance-G_Logo.jpg "Covance-G_Logo") ![quintiles_logo_2017_grey](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/quintiles_logo_2017_grey.jpg?width=300&name=quintiles_logo_2017_grey.jpg "quintiles_logo_2017_grey") ![FDA_G_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/FDA_G_Logo.jpg?width=60&name=FDA_G_Logo.jpg "FDA_G_Logo") ![AstellasG_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/AstellasG_Logo.jpg?width=291&name=AstellasG_Logo.jpg "AstellasG_Logo") ![celgene_logo_download](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/celgene_logo_download.jpg?width=91&name=celgene_logo_download.jpg "celgene_logo_download") ![Boehringer_Ingelheim_Logo-png-updated](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Boehringer_Ingelheim_Logo-png-updated.jpg?width=300&name=Boehringer_Ingelheim_Logo-png-updated.jpg "Boehringer_Ingelheim_Logo-png-updated") ![PRA_Health_Sciences](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/PRA_Health_Sciences.jpg?width=68&name=PRA_Health_Sciences.jpg "PRA_Health_Sciences") ![Astrazeneca logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Astrazeneca%20logo.png?width=322&name=Astrazeneca%20logo.png "Astrazeneca logo") ![Amgen_G_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Amgen_G_Logo.jpg?width=350&name=Amgen_G_Logo.jpg "Amgen_G_Logo") ![Novartis_G_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Novartis_G_Logo.jpg?width=508&name=Novartis_G_Logo.jpg "Novartis_G_Logo") ![abbvie-logo-updated_tmp15240](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/abbvie-logo-updated_tmp15240.jpg?width=365&name=abbvie-logo-updated_tmp15240.jpg "abbvie-logo-updated_tmp15240") ![Merck_GLogo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Merck_GLogo.jpg?width=310&name=Merck_GLogo.jpg "Merck_GLogo") ![Biogen-updated-logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Biogen-updated-logo.jpg?width=258&name=Biogen-updated-logo.jpg "Biogen-updated-logo") ![Ipsen-logo-only](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Ipsen-logo-only.jpg?width=300&name=Ipsen-logo-only.jpg "Ipsen-logo-only") ![Eli_Lilly_and_Company-G_Logo](https://www.statsols.com/hs-fs/hubfs/Master_Images/Client_Logos/Greyscale%20Logos%202018-2019/Eli_Lilly_and_Company-G_Logo.jpg?width=120&name=Eli_Lilly_and_Company-G_Logo.jpg "Eli_Lilly_and_Company-G_Logo") ###### Is there someone in your network that would be interested in our webinar? Share this page by clicking below. [![Share on linkedin](https://7528302.fs1.hubspotusercontent-na1.net/hub/7528302/hubfs/raw_assets/public/mV0_d-web-default-modules_hubspot/img/linkedin-color.png?width=24&name=linkedin-color.png) ](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.statsols.com%2Fen%2Fwebinar%2Fdesigning-studies-with-recurrent-events%3Futm_medium%3Dsocial%26utm_source%3Dlinkedin) [![Share on twitter](https://7528304.fs1.hubspotusercontent-na1.net/hub/7528304/hubfs/raw_assets/public/mV0_d-web-default-modules_hubspot/img/twitter-color.png?width=24&name=twitter-color.png) ](https://twitter.com/intent/tweet?original_referer=https%3A%2F%2Fwww.statsols.com%2Fen%2Fwebinar%2Fdesigning-studies-with-recurrent-events%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&url=https%3A%2F%2Fwww.statsols.com%2Fen%2Fwebinar%2Fdesigning-studies-with-recurrent-events%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&source=tweetbutton&text=) [![Share on email](https://7528311.fs1.hubspotusercontent-na1.net/hub/7528311/hubfs/raw_assets/public/mV0_d-web-default-modules_hubspot/img/email-color.png?width=24&name=email-color.png) ](mailto:?subject=Check+out+https%3A%2F%2Fwww.statsols.com%2Fen%2Fwebinar%2Fdesigning-studies-with-recurrent-events%3Futm_medium%3Dsocial%26utm_source%3Demail&body=Check+out+https%3A%2F%2Fwww.statsols.com%2Fen%2Fwebinar%2Fdesigning-studies-with-recurrent-events%3Futm_medium%3Dsocial%26utm_source%3Demail)